The United States Food and Drug Administration (FDA) has withdrawn several compliance policy guides pertaining to pet food manufacturing practices. According to the FDA, the guides, CPG Sec. 675.400 (Rendered Animal Feed Ingredients) and CPG Sec. 690.300 (Canned Pet Food), had been rendered obsolete by provisions contained in the Food Safety Modernization Act (FSMA).
In a continued commitment to the agency’s modernized risk-based approach to the regulation of animal food under the FDA Food Safety Modernization Act (FSMA), the U.S. Food and Drug Administration today withdrew three outdated Compliance Policy Guides (CPGs) pertaining to the use of certain animal-derived materials in animal food.
These CPGs originally were issued in 1979-80 to explain the FDA’s enforcement priorities regarding use of certain materials in animal food. Today’s action is intended to clarify FDA regulatory policy for manufacturers of animal food (including ingredients) and to remind industry about the agency’s expectations of manufacturers who use materials from “diseased animals and animals that died otherwise than by slaughter” under the the Federal Food, Drug & Cosmetic (FD&C) Act and the FSMA preventive controls for animal food (PCAF) regulations.
The FDA has decided to withdraw CPG Sec. 675.400 – Rendered Animal Feed Ingredients and CPG Sec. 690.300 – Canned Pet Food because of the additional regulatory tools gained through FSMA. Under FSMA and the PCAF regulation, many animal food facilities are now required to establish a food safety plan, including identifying and evaluating known or reasonably foreseeable hazards. Preventive control measures must then be put into place to significantly minimize or prevent hazards requiring preventive controls.
— The U.S. Food and Drug Administration
The FSMA, enacted in 2011, has granted the FDA new approaches to ensure food producers, manufacturers, and processors comply with best practices. These approaches include requiring food makers to develop risk-based controls and safety plans to mitigate risks and hazards.
For more information about the FDA’s recent withdrawal of their compliance policy guides, read their full statement.